Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less
Author:
Publisher
Wiley
Subject
Urology,Oncology
Reference15 articles.
1. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
2. The European Randomized Study of Screening for Prostate Cancer (ERSPC): An Update
3. The European randomized study of screening for prostate cancer
4. Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2;International Journal of Clinical Oncology;2024-03-17
2. Prostate‐specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study);International Journal of Urology;2021-05-18
3. Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening;International Journal of Urology;2019-06-10
4. Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition);International Journal of Urology;2017-07-01
5. Editorial Comment to Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL;International Journal of Urology;2017-06-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3